DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xopenex HFA (Levalbuterol Tartrate) - Published Studies

 
 



Xopenex HFA Related Published Studies

Well-designed clinical trials related to Xopenex HFA (Levalbuterol)

Efficacy of racemic albuterol versus levalbuterol used as a continuous nebulization for the treatment of acute asthma exacerbations: a randomized, double-blind, clinical trial. [2011.03]

Efficacy of racemic albuterol versus levalbuterol used as a continuous nebulization for the treatment of acute asthma exacerbations: a randomized, double-blind, clinical trial. [2011]

Levalbuterol versuss levalbuterol plus ipratropium in the treatment of severe acute asthma. [2010.12]

High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. [2009.08]

A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. [2008.09]

Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. [2008]

Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]

An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]

Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction. [2007.09]

Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]

Evaluation of the efficacy and safety of levalbuterol in subjects with COPD. [2006.08]

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]

A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]

Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma. [2005.12]

Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. [2005.07]

Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]

Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]

Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma. [2004.11]

Well-designed clinical trials possibly related to Xopenex HFA (Levalbuterol)

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. [2012]

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. [2012]

Hypertonic saline and acute wheezing in preschool children. [2012]

The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: a pilot study. [2012]

An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. [2012]

Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial. [2011.12]

Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. [2011.09]

Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea. [2011.09]

Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. [2011.09]

Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. [2011.08.15]

Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. [2011.08]

Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]

Active albuterol or placebo, sham acupuncture, or no intervention in asthma. [2011.07.14]

[Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children]. [2011.07]

Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]

Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. [2011.07]

Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis. [2011.07]

Long-term safety and efficacy of indacaterol, a long-acting beta-agonist, in subjects with COPD: a randomized, placebo-controlled study. [2011.07]

Advancing donor management research: design and implementation of a large, randomized, placebo-controlled trial. [2011.06.14]

Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. [2011.06]

Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. [2011.06]

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. [2011.05.31]

Effect of bronchoconstriction on airway remodeling in asthma. [2011.05.26]

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome. [2011.05.09]

Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. [2011.05.03]

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study. [2011.05]

The effect of antecedent hypoglycaemia on beta-adrenergic sensitivity in healthy participants with the Arg16Gly polymorphism of the beta-adrenergic receptor. [2011.05]

Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD. [2011.05]

Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011.04]

Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children. [2011.04]

Tiotropium versus salmeterol for the prevention of exacerbations of COPD. [2011.03.24]

The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. [2011.03.15]

Comparison of salbutamol efficacy in children--via the metered-dose inhaler (MDI) with Volumatic spacer and via the dry powder inhaler, Easyhaler, with the nebulizer--in mild to moderate asthma exacerbation: a multicenter, randomized study. [2011.03]

Randomized controlled trial to improve care for urban children with asthma: results of the School-Based Asthma Therapy trial. [2011.03]

Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. [2011.03]

Reported pneumonia in patients with COPD: findings from the INSPIRE study. [2011.03]

Efficacy and cost comparisons of bronchodilatator administration between metered dose inhalers with disposable spacers and nebulizers for acute asthma treatment. [2011.03]

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. [2011.02.19]

Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. [2011.02.01]

Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. [2011.02]

The duration of bronchodilation of salmeterol and salbutamol as measured by specific airway conductance in healthy subjects. [2011.02]

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. [2011.02]

Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. [2011.01.15]

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. [2011.01.11]

Lung function response to bronchodilator nebulization via hood in wheezy infants: a pilot study. [2011.01]

Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease. [2011.01]

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease. [2011]

Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. [2011]

The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitis. [2011]

Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD. [2011]

Active albuterol or placebo, sham acupuncture, or no intervention in asthma. [2011]

The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. [2011]

Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial. [2010.12.15]

Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. [2010.12]

A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma. [2010.12]

Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. [2010.11.15]

[Comparative observation on therapeutic effect of chronic persistent bronchial asthma treated with heat-sensitive moxibustion and medication]. [2010.11]

24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol. [2010.11]

Tiotropium bromide step-up therapy for adults with uncontrolled asthma. [2010.10.28]

The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients. [2010.10]

Standard versus low-dose transdermal nitroglycerin: differential effects on the development of tolerance and abnormalities of endothelial function. [2010.10]

Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. [2010.10]

Functional response to inhaled salbutamol and/or ipratropium bromide in Ascaris suum-sensitised cats with allergen-induced bronchospasms. [2010.10]

Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone. [2010.09.07]

A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. [2010.09]

Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma. [2010.09]

Comparable effect of a leukotriene receptor antagonist and long-acting beta-adrenergic agonist in cough variant asthma. [2010.09]

Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial. [2010.09]

Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD. [2010.08.31]

Cardiovascular events in patients with COPD: TORCH study results. [2010.08]

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. [2010.08]

Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma. [2010.08]

Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist. [2010.08]

Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD. [2010.07]

Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms. [2010.07]

Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. [2010.07]

Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. [2010.06]

Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence? [2010.06]

Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. [2010.06]

The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin. [2010.06]

Accuracy of death certificates in COPD: analysis from the TORCH trial. [2010.06]

Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017